Home
About Us
Our Approach
Our Team
Board
Pipeline
News
Honor
Careers
Investment&BD
Contact
中文
ENG
Home
About us
Our Approach
Our Team
Board
Pipeline
News
Honor
Careers
Investment&BD
Contact
CN
COMPANY NEWS
Category
Company News
Enterprise Honor
2023 05
29
TYK Medicines and WuXi STA Launch Comprehensive Strategic Cooperation
Discover More
2023 05
17
TYK Medicine TY-2699a —The CDK7 inhibitorapproved by CDE to conduct clinical trial
Discover More
2023 04
28
TYK Medicines receives CDE Conditional Market Authorization for TY-9591
Discover More
2023 04
07
TYK Medicines TY-4028 —The EGFR/HER2 tyrosine kinase inhibitor approved by FDA to conduct the clinical trial
Discover More
2023 04
04
TYK Medicines will present the research progress and results of 6 innovative drug projects at the 2023 Annual Meeting of American Association for Cancer Research (AACR 2023)
Discover More
2023 02
17
TYK Medicine TY-2699a —The first CDK7 inhibitor in China approved by FDA to conduct clinical trial
TYK Medicine TY-2699a —The first CDK7 inhibitor in China approved by FDA to conduct clinical trial
Discover More
1
2
3
4
5
>